KOR Therapeutics

Better monoclonal antibodies for veterinary medicine

  • Stage Product In Development
  • Industry Biotechnology
  • Location Seattle, WA, USA
  • Currency USD
  • Founded September 2018
  • Employees 2
  • Incorporation Type LLC

Company Summary

KOR is focused on building a platform that allows for more efficient discovery and speciation of monoclonal antibodies for veterinary medicine. We are targeting IL-31 associated with itch and we are also targeting periodontal (dental) disease in dogs.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free